https://insights.citeline.com/scrip/r-and-d/clinical-trials/ideaya-plans-accelerated-approval-filing-of-darovasertib-on-positive-phase-iiiii-data-Z64NRMTLYFHHVOJHCSBQR56JOI/2026-04-13T21:43:30.57Zalways0.5Insightsen2026-04-13T21:43:30.57Zhttps://insights.citeline.com/resizer/vovHfrUMbjyv8icOk_VvGDNSEv0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/V4GYTKKZA5OWVOERCZR73245ZA.jpghttps://insights.citeline.com/scrip/advanced-therapies/cell-therapies/allogene-highlights-potential-for-cema-cel-in-the-community-setting-CKHAMPGDARFHFPON2VK4HYGD2Q/2026-04-13T21:43:25.291Zalways0.5Insightsen2026-04-13T21:43:25.291Zhttps://insights.citeline.com/resizer/RFCOP5SuwJLbrmk_6p99EQhSLJI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HISDQAIJINGCJKEFCQQRMWYEBE.jpghttps://insights.citeline.com/scrip/business/deals/regeneron-taps-telix-for-radiopharma-pact-63J4PJTVOFBZ3AZ6ODREJVSHII/2026-04-13T21:21:01.099Zalways0.5Insightsen2026-04-13T21:21:01.099Zhttps://insights.citeline.com/resizer/G83GmDJa465EuD5lEgnlkV3AWCg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6BJJ3O3EIJHIJHR3UUY7DREPFE.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/revolutions-first-phase-iii-daraxonrasib-data-further-boost-ras-specialists-high-value-4HWVEK5DZZAWXDL2ZWNQI3CYGY/2026-04-13T21:18:35.108Zalways0.5Insightsen2026-04-13T21:18:35.108Zhttps://insights.citeline.com/resizer/KyIOTZ2ysZs_ONATDkpCyEQiKTE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IA3WWRCESZH6XJXD7KH5RSI6OU.jpghttps://insights.citeline.com/hbw-insight/beauty/business/marketing-and-advertising/us-self-regulatory-ad-experts-launch-influencer-certification-program-NK6HOVD7NVFJVILVITDRWRHKTA/2026-04-13T19:50:50.775Zalways0.5Insightsen2026-04-13T19:50:50.775Zhttps://insights.citeline.com/resizer/scc8oHfa3JT0_7RcCpj2IKjtZ0Y=/cloudfront-us-east-1.images.arcpublishing.com/norstella/55RFTDO2UVCSLDPN4G4XKW77AA.jpghttps://insights.citeline.com/medtech-insight/geography/asia/middle-east-crisis-has-south-korea-on-alert-for-medical-product-shortages-OLKPORHSPJH7RHJ7E55EZPV6ZU/2026-04-13T19:07:22.104Zalways0.5Insightsen2026-04-13T19:07:22.104Zhttps://insights.citeline.com/resizer/YfyeCw37wc4WYcs38Ug8dZed0NY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NN3DHTQZRBCLDLNGZXVQ7PAFTY.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/compliance/treasury-whistleblower-rewards-program-furthers-us-government-focus-on-healthcare-fraud-and-abuse-7MQ4WPZGVZBIVPSRVJ7FWQFDGI/2026-04-13T18:51:54.388Zalways0.5Insightsen2026-04-13T18:51:54.388Zhttps://insights.citeline.com/resizer/PCmfguA9bON_V8_3nDGtCvzWhKo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UY4B7BHFANFN3ID2QTO3AFVDQQ.jpghttps://insights.citeline.com/medtech-insight/digital-technologies/cybersecurity/stryker-says-cyberattack-will-affect-first-quarter-2026-results-A6CZQMOD7NF2LFDMEAP733P2QM/2026-04-13T18:45:53.201Zalways0.5Insightsen2026-04-13T18:45:53.201Zhttps://insights.citeline.com/resizer/JHfvnU1V7QxrUqtJOY3WXi8lGJ4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CZWJTDNEENOOXO2APCTSPSRTM4.jpghttps://insights.citeline.com/scrip/top-12-pharma-companies-eli-lilly-shoots-to-the-top-merck-tumbles-WCGHYLQW45D4BKOEYZXBI6WAQI/2026-04-13T16:26:08.82Zalways0.5Insightsen2026-04-13T16:26:08.82Zhttps://insights.citeline.com/resizer/FZegzOb2w3OlcekdPlbloRT_wLM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ULSX6MQFA5NG7NA6MKSSQHX4JY.jpghttps://insights.citeline.com/pink-sheet/regulatory-trackers/european-performance-tracker/ema-prime-scheme2026-04-13T15:34:31.792Zalways0.5Insightsen2026-04-13T15:34:31.792Zhttps://insights.citeline.com/in-vivo/business-strategy/biogens-alisha-alaimo-on-the-companys-next-big-commercial-build-FPC5B2H2UFEMZNBEDQDKT2QBHE/2026-04-13T15:24:56.577Zalways0.5Insightsen2026-04-13T15:24:56.577Zhttps://insights.citeline.com/resizer/GlXQYTzbPO2s0WA78bwsu4Mt9b4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/PZVYM7CMABEN3J6CDRUQML6FC4.jpghttps://insights.citeline.com/hbw-insight/health/rx-to-otc-switch/us-otc-switches-fda-needs-comments-to-guide-public-meeting-congress-wants-progress-report-UJ3DZKUWR5H7THZDT3HMCYSW3A/2026-04-13T15:03:12.078Zalways0.5Insightsen2026-04-13T15:03:12.078Zhttps://insights.citeline.com/resizer/oVmtBVoFamQRJ6gn4MI8biGg6YA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3AFUVFNA5BFVBMVOLN3Y7S3HWE.jpghttps://insights.citeline.com/generics-bulletin/products/biosimilars/celltrion-sees-growth-opportunities-as-lingering-uncertainty-over-us-tariffs-is-resolved-WCMRY53BUREIRANRO6EC3FSZYQ/2026-04-13T14:54:34.551Zalways0.5Insightsen2026-04-13T14:54:34.551Zhttps://insights.citeline.com/resizer/BYCudKTfkpStiyvx_l9kx-YFejM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2RMSVQXF4RD3LMVDBDLKRR5INQ.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-march-2026-YXKHFEV3JFH4XMSAZJHBTTAAOI/2026-04-13T12:41:36.969Zalways0.5Insightsen2026-04-13T12:41:36.969Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/hbw-insight/leadership/interviews/haleon-improving-health-literacy-is-good-for-people-good-for-business-MW4UTQZMVJGC7CPJ5KE3OPHIZ4/2026-04-13T12:21:21.502Zalways0.5Insightsen2026-04-13T12:21:21.502Zhttps://insights.citeline.com/resizer/U8iMyFqK9P9MjvYVsjgPs5ePEBk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BJQ2RQHRENALTJ3WXDM2AJ4SDA.jpghttps://insights.citeline.com/generics-bulletin/products/generics/glp-1s/apotex-breakthrough-sets-stage-for-future-semaglutide-competition-5DRDCUUPPJF6FHKICWBENMF7AI/2026-04-13T10:51:32.666Zalways0.5Insightsen2026-04-13T10:51:32.666Zhttps://insights.citeline.com/resizer/YXPWZjxJPXaWa9rd3bI2XJHmTRM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XAGHZ2ZZYFLOPAWIPCE5EJRDKU.jpghttps://insights.citeline.com/generics-bulletin/products/generics/glenmark-breaks-gsk-hold-on-fluticasone-inhalers-YVIMVOT6RJBZDFIJF3BGO4LZDA/2026-04-13T10:30:53.425Zalways0.5Insightsen2026-04-13T10:30:53.425Zhttps://insights.citeline.com/resizer/5ww6lWPe3uVmq4zgSGlAxN0d1TM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GH3AE2MKZFO43EESC624LETEGQ.jpghttps://insights.citeline.com/generics-bulletin/leadership/interviews/alvotech-looks-to-make-good-on-two-year-bet-56WY2TIECJECBBN6DYAM4B563Q/2026-04-13T10:30:39.453Zalways0.5Insightsen2026-04-13T10:30:39.453Zhttps://insights.citeline.com/resizer/wG58k6vKVtfBvxA8NQH7wIvYSqI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CGDVOTQNJ5GKDECGMZFTBNQYUA.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/eu/eu-data-act-brings-yet-more-questions-for-medtech-WSZRIKUYVVHUPBWQD75J75WGBE/2026-04-13T08:37:28.223Zalways0.5Insightsen2026-04-13T08:37:28.223Zhttps://insights.citeline.com/resizer/8iaXE2rEQ-KNLfWnske1xcwe5pI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JOUHESMRXVCEFIX3VU353L7MYU.jpghttps://insights.citeline.com/pink-sheet/market-access/health-technology-assessment/englands-hta-body-reverses-rejection-for-serivers-voranigo-PJBEGVWBPNCWTGYMBZC6UHL2ZM/2026-04-13T07:59:05.384Zalways0.5Insightsen2026-04-13T07:59:05.384Zhttps://insights.citeline.com/resizer/wtVLpGe_08xNqcyW-_W0rU2kbsc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BDM7H5PEKZCT3B72OW6HTGKREE.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/regulation/mhras-commatteo-points-to-pivotal-period-for-ai-regulation-and-airlock-3-L3CF6HOAD5GYJHOPI6LSK7JMSA/2026-04-13T07:54:34.742Zalways0.5Insightsen2026-04-13T07:54:34.742Zhttps://insights.citeline.com/resizer/3xvRdKXPbZIEXeOxLwRBGVg-PTQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/EY3YRR3VV5F3JC6RGA5UFH3CK4.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/gsk-bets-big-on-its-b7-h4-adc-with-five-phase-iii-trials-upcoming-JREV25AGPBCPFNOXOUA2WEKGQM/2026-04-13T07:36:22.515Zalways0.5Insightsen2026-04-13T07:36:22.515Zhttps://insights.citeline.com/resizer/3yz-1BmypmZUymfPjWOBqLK6djs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BKCBDGA2SVCV3EUMMAHFWQ22PQ.jpghttps://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-O7KEIWGMHBCLZBHKJPKGHOZYPE/2026-04-13T02:44:29.167Zalways0.5Insightsen2026-04-13T02:44:29.167Zhttps://insights.citeline.com/resizer/WXUXwXH3bDpJJ83BI9z04GXgr70=/cloudfront-us-east-1.images.arcpublishing.com/norstella/F2LS6NHSEVFL5MQ55BQ3BYXVPI.jpghttps://insights.citeline.com/scrip/business/financing/adel-raises-33m-in-pre-ipo-round-after-major-sanofi-deal-Y66E37HI4JEL7B373C5HLVG5EU/2026-04-13T00:29:52.989Zalways0.5Insightsen2026-04-13T00:29:52.989Zhttps://insights.citeline.com/resizer/GulgWOv-7M5Q7la0QLcJewUSHv4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/EP3B7N4AFJEJLJDQUCKZZNPK7M.jpghttps://insights.citeline.com/companies/abbott-laboratories-ltd2026-04-13T00:01:15.79Zalways0.5Insightsen2026-04-13T00:01:15.79Z